Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, T&R Biofab Co's Enterprise Value is ₩129,043 Mil.
T&R Biofab Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-4,894 Mil. Therefore, T&R Biofab Co's EV-to-FCF for today is -26.37.
The historical rank and industry rank for T&R Biofab Co's EV-to-FCF or its related term are showing as below:
XKRX:246710'
s EV-to-FCF Range Over the Past 10 Years
Min: -194.26 Med: -12.18 Max: -4.76
Current: -25.57
During the past 12 years, the highest EV-to-FCF of T&R Biofab Co was -4.76. The lowest was -194.26. And the median was -12.18.
XKRX:246710's EV-to-FCF is ranked worse than 100% of 408
companies
in the Medical Devices & Instruments industry
Industry Median: 24.28
vs XKRX:246710: -25.57
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
T&R Biofab Co's PE Ratio (TTM) for today is calculated as:
T&R Biofab Co's share price for today is ₩2200.00.
T&R Biofab Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-877.507.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
T&R Biofab Co EV-to-FCF Related Terms
T&R Biofab Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for T&R Biofab Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:246710 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, T&R Biofab Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T&R Biofab Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where T&R Biofab Co's EV-to-FCF falls into.
T&R Biofab Co's current Enterprise Value is ₩129,043 Mil.
T&R Biofab Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,894 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T&R Biofab Co (XKRX:246710) has a EV-to-FCF of -26.37 as of Sep. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on T&R Biofab Co and its competitors. According to the industry distribution chart, T&R Biofab Co ranks #999999 out of 408 companies in the Medical Devices & Instruments industry.
Is T&R Biofab Co's EV-to-FCF too high?
T&R Biofab Co's current EV-to-FCF is -26.37. Based on the distribution chart, T&R Biofab Co ranks #999999 out of 408 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, T&R Biofab Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does T&R Biofab Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, T&R Biofab Co ranks #999999 out of 408 companies for EV-to-FCF. This places T&R Biofab Co in the lower half of its industry. The industry median EV-to-FCF is 24.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.28, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on T&R Biofab Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T&R Biofab Co's current EV-to-FCF is -26.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T&R Biofab Co stock overvalued right now?
Based on GuruFocus' analysis, T&R Biofab Co (XKRX:246710) is currently considered Possible Value Trap. The stock's GF Value™ is ₩19,469.96, compared to a current price of ₩2,200.00 — trading 88.7% below its estimated fair value. The current EV-to-FCF is -26.37. T&R Biofab Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For T&R Biofab Co (XKRX:246710), the current EV-to-FCF is -26.37 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is T&R Biofab Co (XKRX:246710) Overvalued in 2026?
Based on GuruFocus' analysis, T&R Biofab Co stock appears to be undervalued.
The current stock price of ₩2,200.00 is trading 88.7% below its estimated GF Value™ of ₩19,469.96.
GuruFocus considers T&R Biofab Co to be Possible Value Trap.
Key valuation signals for XKRX:246710:
EV-to-FCF: -26.37
GF Value™: ₩19,469.96 vs. price of ₩2,200.00 (88.7% below fair value)
No single metric tells the full story. See the XKRX:246710 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
57GF Score
Get the complete analysis for XKRX:246710
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246710 has been successfully added to your 
